Literature DB >> 18281532

Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression.

Vyomesh Patel1, Brian L Hood, Alfredo A Molinolo, Norman H Lee, Thomas P Conrads, John C Braisted, David B Krizman, Timothy D Veenstra, J Silvio Gutkind.   

Abstract

PURPOSE: Squamous cell carcinoma of the head and neck (HNSCC), the sixth most prevalent cancer among men worldwide, is associated with poor prognosis, which has improved only marginally over the past three decades. A proteomic analysis of HNSCC lesions may help identify novel molecular targets for the early detection, prevention, and treatment of HNSCC. EXPERIMENTAL
DESIGN: Laser capture microdissection was combined with recently developed techniques for protein extraction from formalin-fixed paraffin-embedded (FFPE) tissues and a novel proteomics platform. Approximately 20,000 cells procured from FFPE tissue sections of normal oral epithelium and well, moderately, and poorly differentiated HNSCC were processed for mass spectrometry and bioinformatic analysis.
RESULTS: A large number of proteins expressed in normal oral epithelium and HNSCC, including cytokeratins, intermediate filaments, differentiation markers, and proteins involved in stem cell maintenance, signal transduction, migration, cell cycle regulation, growth and angiogenesis, matrix degradation, and proteins with tumor suppressive and oncogenic potential, were readily detected. Of interest, the relative expression of many of these molecules followed a distinct pattern in normal squamous epithelia and well, moderately, and poorly differentiated HNSCC tumor tissues. Representative proteins were further validated using immunohistochemical studies in HNSCC tissue sections and tissue microarrays.
CONCLUSIONS: The ability to combine laser capture microdissection and in-depth proteomic analysis of FFPE tissues provided a wealth of information regarding the nature of the proteins expressed in normal squamous epithelium and during HNSCC progression, which may allow the development of novel biomarkers of diagnostic and prognostic value and the identification of novel targets for therapeutic intervention in HNSCC.

Entities:  

Mesh:

Year:  2008        PMID: 18281532     DOI: 10.1158/1078-0432.CCR-07-1497

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  71 in total

1.  Proteomic analysis of laser microdissected melanoma cells from skin organ cultures.

Authors:  Brian L Hood; Jelena Grahovac; Melanie S Flint; Mai Sun; Nuno Charro; Dorothea Becker; Alan Wells; Thomas P Conrads
Journal:  J Proteome Res       Date:  2010-07-02       Impact factor: 4.466

2.  Accumulation of the SET protein in HEK293T cells and mild oxidative stress: cell survival or death signaling.

Authors:  Andréia M Leopoldino; Cristiane H Squarize; Cristiana B Garcia; Luciana O Almeida; Cezar R Pestana; Ana C M Polizello; Sérgio A Uyemura; Eloiza H Tajara; J Silvio Gutkind; Carlos Curti
Journal:  Mol Cell Biochem       Date:  2011-12-06       Impact factor: 3.396

3.  Membrane-type MMPs are indispensable for placental labyrinth formation and development.

Authors:  Ludmila Szabova; Mee-Young Son; Joanne Shi; Marek Sramko; Susan S Yamada; William D Swaim; Patricia Zerfas; Stacie Kahan; Kenn Holmbeck
Journal:  Blood       Date:  2010-09-21       Impact factor: 22.113

Review 4.  Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer.

Authors:  James F Rusling; Challa V Kumar; J Silvio Gutkind; Vyomesh Patel
Journal:  Analyst       Date:  2010-07-08       Impact factor: 4.616

5.  Novel surgical approaches for sampling the ovarian surface epithelium and proximal fluid proteome.

Authors:  Bunja Rungruang; Brian L Hood; Mai Sun; Ebony Hoskins; Thomas P Conrads; Kristin K Zorn
Journal:  J Proteome Res       Date:  2010-10-15       Impact factor: 4.466

Review 6.  Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.

Authors:  Alexandra Lucs; Benjamin Saltman; Christine H Chung; Bettie M Steinberg; David L Schwartz
Journal:  Head Neck       Date:  2012-01-27       Impact factor: 3.147

7.  Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumors.

Authors:  Martin H Pedersen; Brian L Hood; Hans Christian Beck; Thomas P Conrads; Henrik J Ditzel; Rikke Leth-Larsen
Journal:  Oncoimmunology       Date:  2017-03-16       Impact factor: 8.110

8.  Proteomic and bioinformatic profile of primary human oral epithelial cells.

Authors:  Santosh K Ghosh; Elizabeth Yohannes; Gurkan Bebek; Aaron Weinberg; Bin Jiang; Belinda Willard; Mark R Chance; Michael T Kinter; Thomas S McCormick
Journal:  J Proteome Res       Date:  2012-10-16       Impact factor: 4.466

9.  Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens.

Authors:  Darue A Prieto; Donald J Johann; Bih-Rong Wei; Xiaoying Ye; King C Chan; Dwight V Nissley; R Mark Simpson; Deborah E Citrin; Crystal L Mackall; W Marston Linehan; Josip Blonder
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

10.  Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS.

Authors:  Lang-Ming Chi; Chien-Wei Lee; Kai-Ping Chang; Sheng-Po Hao; Hang-Mao Lee; Ying Liang; Chuen Hsueh; Chia-Jung Yu; I-Neng Lee; Yin-Ju Chang; Shih-Ying Lee; Yuan-Ming Yeh; Yu-Sun Chang; Kun-Yi Chien; Jau-Song Yu
Journal:  Mol Cell Proteomics       Date:  2009-03-18       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.